STRATA Skin Sciences, Inc. — Director's Dealing 2022

Apr 2, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STRATA Skin Sciences, Inc. (SSKN)
CIK: 0001051514
Period of Report: 2022-03-30

Reporting Person: Moccia Robert Joseph (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-30	Employee Stock Option	$1.45	A	100000	Acquired	2032-03-30	Common Stock (100000)	Direct
2022-03-30	Employee Stock Option	$1.45	A	60000	Acquired	2032-03-30	Common Stock (60000)	Direct

Footnotes

F1: 1. Vesting of these options depends upon the Company's achievement of a specified net revenue in relation to the Company's budget over a 12-month period from January 1, 2022 through December 31, 2022. Each option represents a contingent right to receive one share of the Company's common stock at Target performance. The "Target" number of shares is reported. Possible payout ranges from 0% of Target if the Threshold goal is not met, 95% of Target if the Threshold is met but the Target goal is not met, 100% of Target if the Target goal is met but the Stretch goal is not met, and 105% of Target if the Stretch goal is met or exceeded. The options are otherwise subject to acceleration and cancellation in certain specified circumstances.

F2: 2. Vesting of these options depends upon the Company's achievement of a specified five trading day volume weighted average per share price ending on December 31, 2022 in relation to the Company's budget target for December 31, 2022, subject to acceleration and cancellation in certain specified circumstances.